Qureight

Qureight, a Cambridge-based health tech company, has secured $20m (£15m) in Series B funding to expand its AI-powered clinical trial imaging platform.

Summary of transaction details:

• Value: $20m (£15m)
• Sector: Healthcare & Biotech
• Advisor: Not disclosed
• Key Entities: Qureight, Molten Ventures
• Location: Cambridge, UK

Note: The funding will enable Qureight to construct a specialised AI imaging laboratory and expand its imaging CRO services beyond its core footprint in lung fibrosis into adjacent therapeutic areas, underscoring the potential of AI to accelerate discovery and transform clinical research.